Roche Pays US$8.3 Billion for Biotech Company, InterMune

By Sarah Brown, Contributing Reporter

RIO DE JANEIRO, BRAZIL - Roche, a large global pharmaceutical company, paid a high premium in the full takeover of American, InterMune. This is the latest move for Roche in an attempt to generate a potential US$1 billion gain in the treatment of respiratory disorders sector, the world’s largest drug market.

With a wide global presence, including offices in São Paulo, Roche aims to diversify its . . .

To read the full NEWS and much more, Subscribe to our Premium Membership Plan. Already Subscribed?